Evidence map›Paper›PMID 42260766›Full record

ArticleChinese medical journal2026

Anti-PD-1 monoclonal antibody suppresses hepatitis B virus in patients with hepatocellular carcinoma.

Chuanhua Zhao, Yanqiao Zhang, Gang Wang, Weiqing Chen, Li Zhuang, Shanzhi Gu, Jinfang Zheng, Lei Han, Zujiang Yu, Chang Liu and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chuanhua ZhaoDepartment of Gastrointestinal Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China.
Yanqiao ZhangHarbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China.
Gang WangBaoji Central Hospital, Baoji, Shaanxi 721008, China.
Weiqing ChenChongqing University Cancer Hospital, Chongqing 400030, China.
Li ZhuangYunnan Cancer Hospital, Kunming, Yunnan 650118, China.
Shanzhi GuHunan Cancer Hospital, Changsha, Hunan 410013, China.
Jinfang ZhengHainan General Hospital, Haikou, Hainan 570311, China.
Lei HanAffiliated Hospital of Jining Medical University, Jining, Shandong 272029, China.
Zujiang YuThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
Chang LiuBeijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.
Dongfang LiuBeijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.
Liangzhi XieBeijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.
Jianming XuDepartment of Gastrointestinal Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42260766
PMCPMC13384708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.